Weight-Loss Drugs Mental Health Boost | European Study | AcademicJobs
A landmark study from Sweden's Karolinska Institutet reveals GLP-1 drugs like semaglutide reduce worsening depression by 44%, anxiety by 38%, offering new hope for comorbid conditions.
european-universitiesresearch-publication-newsglp-1-agonists

